NCT07011979 SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
| NCT ID | NCT07011979 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Inflammatory Bowel Disease (IBD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-01-07 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-01-07 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to investigate characteristics of individuals at high risk for developing Inflammatory Bowel Disease (IBD) in order to identify risk factors associated with its incidence. The main question it aims to answer is: What are the risk factors for developing Inflammatory Bowel Disease? Researchers will compare groups at high risk for IBD to healthy populations and to patients already diagnosed with IBD. Participants will * undergo assessments of general demographic and clinical characteristics. * be monitored for symptoms using questionnaires administered at regular intervals. * have blood tests and stool examinations performed. In cases where participants undergo colonoscopy for routine clinical indications, gut biopsies will also be performed.
Eligibility Criteria
Inclusion Criteria: * first-degree relatives of Inflammatory Bowel Disease patients * patients who are diagnosed with autoimmune diseases * patients with functional gastrointestinal disorders who are ASCA-positive Exclusion Criteria: * Patients with symptoms such as a 10% weight loss within 3 months, abdominal pain, hematochezia, or diarrhea will undergo colonoscopy, and those diagnosed with Inflammatory Bowel Disease will be excluded. * Treatment history of Diabetes Mellitus, Irritable Bowel Syndrome, or colon cancer.
Frequently Asked Questions
Who can join the NCT07011979 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, studying Inflammatory Bowel Disease (IBD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07011979 currently recruiting?
Yes, NCT07011979 is actively recruiting participants. Visit ClinicalTrials.gov or contact Seoul National University Hospital to inquire about joining.
Where is the NCT07011979 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07011979 clinical trial?
NCT07011979 is sponsored by Seoul National University Hospital. The trial plans to enroll 500 participants.